BackgroundThe treatment of multisystem inflammatory syndrome in children unresponsive to first-line therapies (IVIG and/or steroids) is challenging. The effectiveness of IL-1 receptor antagonist, anakinra, is debated.Patients and methodsWe conducted an anonymous retrospective multicenter study on MIS-C patients treated with anakinra in Italy...
-
2023 (v1)PublicationUploaded on: February 23, 2024
-
2019 (v1)Publication
To present the results of a Delphi consensus survey among Italian paediatric and adult rheumatologists on transitional care (TC) of young people (YP) with juvenile idiopathic arthritis (JIA).
Uploaded on: March 27, 2023 -
2018 (v1)Publication
Background In 2012, a European initiative called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe for children and young adults with rheumatic diseases. Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
To study growth and puberty in a multi-national longitudinal prospective cohort of juvenile dermatomyositis (JDM).
Uploaded on: April 14, 2023 -
2010 (v1)Publication
Objective. To assess health-related quality of life (HRQOL) in abatacept-treated children/adolescents with juvenile idiopathic arthritis (JIA).Methods. In this phase III, double-blind, placebo-controlled trial, subjects with active polyarticular course JIA and an inadequate response/intolerance to >= 1 disease-modifying antirheumatic drug...
Uploaded on: April 14, 2023 -
2022 (v1)Publication
To evaluate in real-life the effectiveness and safety of canakinumab in Italian patients with systemic juvenile idiopathic arthritis (sJIA).
Uploaded on: February 4, 2024